Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia
Cornelis Blauwendraat, Xylena Reed, Lynne Krohn, et al.
Brain (2019) Vol. 143, Iss. 1, pp. 234-248
Open Access | Times Cited: 200

Showing 1-25 of 200 citing articles:

Parkinson’s disease: etiopathogenesis and treatment
Joseph Jankovic, Eng King Tan
Journal of Neurology Neurosurgery & Psychiatry (2020) Vol. 91, Iss. 8, pp. 795-808
Open Access | Times Cited: 808
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Jun Guo, Xiuqing Huang, Lin Dou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 745
Genetics of Parkinson's disease: An introspection of its journey towards precision medicine
Sara Bandrés‐Ciga, Mónica Díez-Fairén, Jonggeol Jeff Kim, et al.
Neurobiology of Disease (2020) Vol. 137, pp. 104782-104782
Open Access | Times Cited: 312
Microglia and astrocyte dysfunction in parkinson's disease
Tae‐In Kam, Jared T. Hinkle, Ted M. Dawson, et al.
Neurobiology of Disease (2020) Vol. 144, pp. 105028-105028
Open Access | Times Cited: 270
Genetics and Pathogenesis of Parkinson's Syndrome
Hui Ye, Laurie Robak, Meigen Yu, et al.
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 95-121
Open Access | Times Cited: 220
The Genetics of Parkinson’s Disease and Implications for Clinical Practice
Jacob Day, Stephen Mullin
Genes (2021) Vol. 12, Iss. 7, pp. 1006-1006
Open Access | Times Cited: 157
GBA Variants and Parkinson Disease: Mechanisms and Treatments
Laura Smith, Anthony H.V. Schapira
Cells (2022) Vol. 11, Iss. 8, pp. 1261-1261
Open Access | Times Cited: 139
Molecular genetics of Parkinson’s disease: Contributions and global trends
Manabu Funayama, Kenya Nishioka, Yuanzhe Li, et al.
Journal of Human Genetics (2022) Vol. 68, Iss. 3, pp. 125-130
Open Access | Times Cited: 115
GP2: The Global Parkinson's Genetics Program

Movement Disorders (2021) Vol. 36, Iss. 4, pp. 842-851
Open Access | Times Cited: 114
Monogenic Parkinson’s Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing
Fangzhi Jia, Avi Fellner, Kishore R. Kumar
Genes (2022) Vol. 13, Iss. 3, pp. 471-471
Open Access | Times Cited: 94
Animal models of Parkinson’s disease: bridging the gap between disease hallmarks and research questions
Axelle Dovonou, Cyril Bolduc, Victoria Soto Linan, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 54
Cell biology of Parkinson's disease: Mechanisms of synaptic, lysosomal, and mitochondrial dysfunction
Sarah M. Brooker, G Naylor, Dimitri Krainc
Current Opinion in Neurobiology (2024) Vol. 85, pp. 102841-102841
Closed Access | Times Cited: 26
Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same
Per Borghammer, Niels Okkels, Daniel Weintraub
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 3, pp. 383-397
Open Access | Times Cited: 17
The role of genetics in Parkinson’s disease: a large cohort study in Chinese mainland population
Yuwen Zhao, Lixia Qin, Hongxu Pan, et al.
Brain (2020) Vol. 143, Iss. 7, pp. 2220-2234
Open Access | Times Cited: 139
“LRRK2: Autophagy and Lysosomal Activity”
Marta Madureira, Natalie Connor‐Robson, Richard Wade‐Martins
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 114
Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics
Konstantin Senkevich, Ziv Gan‐Or
Parkinsonism & Related Disorders (2019) Vol. 73, pp. 60-71
Open Access | Times Cited: 110
Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders
Sujay Paul, Luis Alberto Bravo-Vázquez, Samantha Pérez Uribe, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1698-1698
Open Access | Times Cited: 98
Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource
Hirotaka Iwaki, Hampton L. Leonard, Mary B. Makarious, et al.
Movement Disorders (2021) Vol. 36, Iss. 8, pp. 1795-1804
Open Access | Times Cited: 97
The Role of Cholesterol in α‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease
Patricia García‐Sanz, Johannes M. F. G. Aerts, Rosario Moratalla
Movement Disorders (2020) Vol. 36, Iss. 5, pp. 1070-1085
Open Access | Times Cited: 90
The Parkinson's Disease Genome‐Wide Association Study Locus Browser
Francis P. Grenn, Jonggeol J. Kim, Mary B. Makarious, et al.
Movement Disorders (2020) Vol. 35, Iss. 11, pp. 2056-2067
Open Access | Times Cited: 87
Sequence of clinical and neurodegeneration events in Parkinson’s disease progression
Neil P. Oxtoby, Louise‐Ann Leyland, Leon M. Aksman, et al.
Brain (2021) Vol. 144, Iss. 3, pp. 975-988
Open Access | Times Cited: 81
Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score
Hirotaka Iwaki, Cornelis Blauwendraat, Mary B. Makarious, et al.
Movement Disorders (2020) Vol. 35, Iss. 5, pp. 774-780
Open Access | Times Cited: 73
Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression
Roberto A. Ortega, Cuiling Wang, Deborah Raymond, et al.
JAMA Network Open (2021) Vol. 4, Iss. 4, pp. e215845-e215845
Open Access | Times Cited: 62
Identification of sixteen novel candidate genes for late onset Parkinson’s disease
Alessandro Gialluisi, Mafalda Giovanna Reccia, Nicola Modugno, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 58
Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments
Matthew E. Gegg, Elisa Menozzi, Anthony H.V. Schapira
Neurobiology of Disease (2022) Vol. 166, pp. 105663-105663
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top